Boothbay Fund Management, LLC Reata Pharmaceuticals Inc Put Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $819,550 - $1.56 Million	37,000 New	37,000 $1.41 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $1.65 Million - $2.71 Million	68,500 Added 678.22%	78,600 $2.58 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $960,375 - $4.16 Million	-37,500 Reduced 78.78%	10,100 $266,000
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $2.78 Million - $3.98 Million	27,800 Added 140.4%	47,600 $4.79 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $1.55 Million - $3 Million	19,800 New	19,800 $2.8 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.